Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2016

Changes in the carrying amount of goodwill (restated), by reportable segment, were as follows (in millions):



	CHCA			CHCI			RX			Specialty Sciences			Other			Total
Balance at June 28, 2014 (restated)	$	1,827.9		$	248.2		$	1,098.7		$	200.7		$	97.6		$	3,473.1
Business acquisitions	4.8			1,269.6			—			—			—			1,274.4
Impairments	(6.8		)	—			—			—			—			(6.8		)
Currency translation adjustment	(1.5		)	12.4			(8.0		)	—			(9.4		)	(6.5		)
Purchase accounting adjustments	(7.2		)	—			(4.7		)	(1.1		)	—			(13.0		)
Balance at June 27, 2015 (restated)	1,817.2			1,530.2			1,086.0			199.6			88.2			4,721.2
Business acquisitions	9.7			87.4			—			—			—			97.1
Changes in assets held for sale	(13.0		)	—			—			—			(14.6		)	(27.6		)
Currency translation adjustment	(0.8		)	(53.3		)	(1.9		)	—			(2.1		)	(58.1		)
Purchase accounting adjustments	1.2			418.9			—			—			—			420.1
Balance at December 31, 2015 (restated)	1,814.3			1,983.2			1,084.1			199.6			71.5			5,152.7
Business acquisitions	—			—			1.7			—			—			1.7
Purchase accounting adjustments	17.2			(16.5		)	—			—			—			0.7
Impairments	(24.5		)	(868.4		)	—			(199.6		)	—			(1,092.5		)
Changes in assets held for sale	4.5			—			—			—			9.0			13.5
Currency translation adjustment	(0.9		)	(27.5		)	0.8			—			0.9			(26.7		)
Balance at December 31, 2016	$	1,810.6		$	1,070.8		$	1,086.6		$	—		$	81.4		$	4,049.4

The reporting units had the following remaining goodwill balances as of December 31, 2016:



Reporting Unit	Goodwill Remaining in Reporting Unit		Segment
Animal Health	$	178.9	CHCA
BCH-Belgium	$	63.2	CHCI
BCH-ROW	$	816.5	CHCI

Other intangible assets and the related accumulated amortization consisted of the following (in millions):



	December 31, 2016				December 31, 2015				June 27, 2015
	Gross		Accumulated Amortization		Gross		Accumulated Amortization		Gross		Accumulated Amortization
					Restated		Restated		Restated		Restated
Definite-lived intangibles:
Distribution and license agreements, supply agreements	$	305.6	$	120.4	$	242.4	$	77.7	$	218.9	$	58.4
Developed product technology, formulations, and product rights	1,418.1		526.0		1,387.6		426.0		1,029.6		383.1
Customer relationships and distribution networks	1,489.9		307.5		1,520.7		193.0		1,750.0		146.3
Trademarks, trade names, and brands	1,189.3		55.3		539.4		22.8		340.8		11.5
Non-compete agreements	14.3		11.2		15.2		12.7		14.7		11.9
Total definite-lived intangibles	$	4,417.2	$	1,020.4	$	3,705.3	$	732.2	$	3,354.0	$	611.2
Indefinite-lived intangibles:
Trademarks, trade names, and brands	$	50.5	$	—	$	1,868.1	$	—	$	2,257.3	$	—
In-process research and development	64.0		—		48.2		—		5.8		—
Total indefinite-lived intangibles	114.5		—		1,916.3		—		2,263.1		—
Total other intangible assets	$	4,531.7	$	1,020.4	$	5,621.6	$	732.2	$	5,617.1	$	611.2

Intangible asset impairments taken are as follows (in millions):



	Year Ended						Six Months Ended		Year Ended
	December 31, 2016						December 31, 2015		June 28, 2014
($ in millions)	Indefinite-Lived Intangible Assets		Definite-Lived Intangible Assets		IPR&D		Indefinite-Lived Intangible Assets		IPR&D
CHCA	$	0.4	$	—	$	—	$	—	$	—
CHCI	849.1		321.4		3.5		185.1		—
RX	—		342.2		—		—		6.0
Other	—		2.0		—		—		—
	$	849.5	$	665.6	$	3.5	$	185.1	$	6.0

The remaining weighted-average useful life for our amortizable intangible assets by asset class at December 31, 2016 was as follows:



Amortizable Intangible Asset Category		Remaining Weighted-Average Useful Life (Years)
Distribution and license agreements, supply agreements		7
Developed product technology, formulations, and product rights		12
Customer relationships and distribution networks		18
Trademarks, trade names, and brands		20
Non-compete agreements		3

Our estimated future amortization expense is as follows (in millions):